Cancer Drugs: Strategies For Patenting Antibody-Drug Conjugate Inventions | Foley & Lardner LLP
Antibody-drug conjugate (ADC) is a promising class of cancer treatments with accelerating U.S. Food and Drug Administration (FDA) approval and rapidly growing market size as discussed...
Source: jdsupra.com